Article

(2018) COMPARE CPM-RMI Trial: Intramyocardial Transplantation of Autologous Bone Marrow-Derived CD133(+) Cells and MNCs during CABG in Patients with Recent MI: A Phase II/III, Multicenter, Placebo-Controlled, Randomized, Double-Blind Clinical Trial. Cell Journal. pp. 267-277. ISSN 2228-5806

(2012) Five-Year Follow-up of the Local Autologous Transplantation of CD133+Enriched Bone Marrow Cells in Patients with Myocardial Infarction. Archives of Iranian Medicine. pp. 32-35. ISSN 1029-2977